Russell Carlston
Podiatrist · Holdrege, NENPI 1710369095
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by KCI USA, Inc. at 31.3% of the total. Reporting peaked in 2020 at $1,869 and has fallen 63.9% since, to $675 in 2025.
Across 103 payments — averaging $57.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KCI USA, Inc.$2K
- Conetic Solutions, Inc.$2K
- Organogenesis Inc.$1K
- Johnson & Johnson$504
- Treace Medical Concepts, Inc.$152
- Kerecis Limited$100
- plus $534 from 17 others
What the payments were for
- Travel & lodging$1,74029%
- Food & beverage$2,99250%
- Education$1,20020%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KCI USA, Inc. | 6 | $1,855 |
| Conetic Solutions, Inc. | 5 | $1,600 |
| Organogenesis Inc. | 52 | $1,187 |
| Johnson & Johnson(2 entities) | 8 | $504 |
| Treace Medical Concepts, Inc. | 2 | $152 |
| Kerecis Limited | 2 | $100 |
| Amgen | 6 | $95 |
| Sanara Medtech Inc. | 1 | $76 |
| Novo Nordisk | 4 | $64 |
| Averitas Pharma Inc. | 2 | $46 |
| Smith+Nephew | 1 | $31 |
| Aroa Biosurgery Incorporated | 1 | $27 |
| Pfizer | 2 | $27 |
| GSK | 2 | $26 |
| Vertex | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| AbbVie | 1 | $18 |
| Convatec Inc. | 1 | $17 |
| Roche Diagnostics Corporation | 1 | $17 |
| AstraZeneca | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
| Corcept Therapeutics | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVENA$1,293
- ABTHERA$707
- VAC VERAFLO CLEANSE CHOICE$707
- VAC VERAFLO$707
- SNAP$540
- MOTOBAND$242
- LAPIPLASTY SYSTEM 1$138
- CYGNUS DUAL$116
- PURAPLY WOUND MATRIX$113
- ViviGen$107
How this compares
$5,932 in reported general payments places this provider in the 75th percentile of 29 podiatrist providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 13 | $2,116 |
| Duloxetine Hcl | 88 | $971 |
| Gabapentin | 138 | $818 |
| Doxycycline Hyclate | 36 | $458 |
| Ketoconazole | 12 | $407 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 57 | $308 |
| Meloxicam | 59 | $234 |
| Pregabalin | 11 | $170 |
| Triamcinolone Acetonide | 15 | $152 |
| Prednisone | 28 | $115 |
| Cephalexin | 20 | $86 |
| Terbinafine Hcl | 11 | $74 |
| Tramadol Hcl | 17 | $42 |
| Allopurinol | 15 | $17 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Holdrege
- Donald BuddeckeBellevue$47K
- Nathan PenneyOmaha$16K
- Glenn YorkOmaha$10K
- Emlyn ForsungOmaha$9K
- Michael CullenOmaha$8K
- Scott ShindlerWausa$8K
- Katherine TernentLincoln$7K
- Robert HinzeMcCook$5K
- Jonathan LittlePapillion$5K
- Chad SummyOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.